Skip to main content
. Author manuscript; available in PMC: 2019 Oct 1.
Published in final edited form as: Clin Cancer Res. 2018 Nov 16;25(7):2042–2048. doi: 10.1158/1078-0432.CCR-18-1625

Figure 1.

Figure 1.

Chimeric antigen receptors are composed of an extracellular antigen-binding domain, typically in the form of an antibody-derived single-chain variable fragment (scFv), translated in tandem with assorted intracellular signaling regions that have differential effects on T-cell proliferation, effector function and survival.